Navigation Links
Biologic Treatment of Rheumatoid Arthritis Is Low in Brazil, According to Kantar Health Research
Date:9/14/2013

New York, NY (PRWEB) September 14, 2013

Despite the impairment caused by their disease, only 13 percent of rheumatoid arthritis patients in Brazil who are eligible for biologic therapy according to clinical guidelines are actually using a biologic, according to new findings from Kantar Health’s National Health and Wellness Survey (NHWS). The research will be presented today at the ISPOR (International Society for Pharmacoeconomics and Outcomes Research) 4th Latin America Conference in Buenos Aires.

Recently updated treatment recommendations from the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) suggest that rheumatoid arthritis patients who fail to respond to a disease-modifying antirheumatic drug (DMARD) be administered a biologic DMARD. According to NHWS, more than half of moderate-to-severe rheumatoid arthritis patients in Brazil are eligible for biologic DMARD therapy according to these guidelines; however, only 13 percent actually use these therapies.

Biologic DMARDs are injectable treatments that are typically much more expensive than traditional DMARDs. Only 20 percent of rheumatoid arthritis patients in Brazil reported a monthly income of more than R$10,000, suggesting that they would have significantly worse access to an expensive treatment. In addition, nearly 30 percent of these patients said they have a fear of needles, which might also affect use of an injectable therapy.

“The majority of patients with rheumatoid arthritis in Brazil have high levels of disease severity, and these patients report more physical impairment,” said Dave Pomerantz, Senior Vice President, Kantar Health. “However, treatment rates among patients with rheumatoid arthritis were generally modest overall, particularly with respect to the biologic DMARDs. Our research suggests that poor access to these medications and patients’ attitudes may be hindering uptake of biologics, which would delay the progress of the disease.”

Visit Kantar Health’s website to download the full poster, “Unmet Needs and Biologic Use among Patients with Rheumatoid Arthritis in Brazil.”

About the National Health and Wellness Survey (NHWS)
The study’s results were drawn from the 2011 and 2012 Brazil NHWS, a nationally representative, self-administered survey conducted annually. Topics covered include the health status, attitudes, behaviors and outcomes among adults 18 or older.

Kantar Health conducts the NHWS in the U.S., Europe, Asia and Latin America. The survey is the largest self-reported dataset in the healthcare industry.

About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech, and medical device and diagnostic companies. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit http://www.kantarhealth.com.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11108198.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Kalen Biomedical, LLC Signs Distribution Agreement with Beijing LeBo Biological
2. Molecular Imaging, Inc. Announces New Webinar: Advancing Discovery and Development of Biologics Through Non-Invasive Biodistribution Imaging
3. BCC Research Publishes a New Report On Global Markets for Surveillance and Monitoring of Explosive, Chemical, Biological, and Nuclear (Ecbn) Hazards.
4. Distinct brain disorders biologically linked
5. Biological and Biochemical Product Manufacturing in China Industry Research Report – Now Available from IBISWorld
6. BiologicsMD, Inc. Announces The Appointment of J. David Owens as Chief Executive Officer
7. Statement from the Sensory Processing Disorder Foundation Endorsing New Breakthrough Study Revealing Biological Basis for Sensory Processing Disorders in Kids
8. Advancement in Biologic Protein Expression Webinar Hosted by Selexis SA
9. Silk and cellulose biologically effective for use in stem cell cartilage repair
10. Frequently used biologic agents might cause acute liver injury
11. Men Biologically Programmed to Steer Clear of Friends Wives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2017)... ... , ... The weather is heating up and the days are getting longer, ... aware that the summer months provide more than warmer temperatures that are perfect for ... negatively affected from direct exposure to the sun. When it comes to the security ...
(Date:6/23/2017)... ... June 23, 2017 , ... "The Better ... ultimately do significant harm to people with all chronic conditions, including mental illnesses, ... leaves in place the Affordable Care Act (ACA) requirement that insurers cover pre-existing ...
(Date:6/23/2017)... , ... June 24, 2017 , ... Studies show evidence ... reduce the risk of visual loss in these patients. , But how often do ... or smoking cessation to patients at risk of or with early symptoms of AMD? ...
(Date:6/23/2017)... ... June 23, 2017 , ... Military Connection ... denied entry to the JFK Virgin Atlantic lounge. , Bensko is no stranger ... six years ago, Bensko dedicated her life to supporting our wounded veterans. A world-class ...
(Date:6/23/2017)... ... ... The Aesthetic Channel has recently highlighted Dr. Ben Talei’s unique approach to ... technique that he calls the AuraLyft Facelift. The AuraLyft does more than ... expect to look refreshed, rejuvenated, and revitalized. , Dr. Talei’s unique approach stems ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... 14, 2017  ivWatch LLC, a medical device company ... (IV) therapy, is pleased to announce it was the ... Hospital Supplies and Equipment at the 2017 Medical Design ... medtech industry. The award was presented by Medical Device ... Center in New York during ...
(Date:6/12/2017)... Kineta, Inc., a biotechnology company focused on the development of ... R&D and Head of Virology Kristin Bedard has been invited ... and Beyond meeting sponsored by Life Science Washington.  This ... AM PDT at the Agora Conference Center in ... be joined by other leaders in infectious disease research and ...
(Date:6/9/2017)... INDIANAPOLIS , June 9, 2017 /PRNewswire/ ... diabetes. In a further effort to help spread lessons ... this condition, the International Diabetes Federation (IDF) and Eli ... come together for the second phase of the Bringing ... (BRIDGES 2), reaffirming their commitment to helping people with ...
Breaking Medicine Technology: